Diaceutics Growth, Revenue, Number of Employees and Funding

Overview

Location:
Parsippany, NJ USA
Total Funding:$5.3M
Industry:Pharma
Founded:2005
Lead Investor(s):WhiteRock Capital Partners, Silicon Valley Bank
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Diaceutics's estimated revenue is currently $16.4M per year.
  • Diaceutics received $5.0M in venture funding in April 2018.
  • Diaceutics's estimated revenue per employee is $156000
  • Diaceutics's total funding is $5.3M.

Employee Data

  • Diaceutics has 105 Employees.
  • Diaceutics grew their employee count by 38% last year.
  • Diaceutics currently has 1 job openings.

Executive Contacts

NameTitle
Steven VitaleManaging Director, Marketing
Scott DeVoreDirector, Key Accounts & Global Alliances
Steven PriceSenior Director Pharmaceutical Consulting, Engagement Team
Kevin EntwistleSenior Director, IVD Commercialization
Bethany SlifkoDirector
Ruchit ParikhDirector, Pharmaceutical Consulting
Jamil GlennAssociate Marketing Director
Wayne CaldwellMarketing Director
Peter DePauloDirector, Software Engineer - Special Projects: Data Applications and Products
Kevin MonaghanSenior Director Finance

What Is Diaceutics?

Diaceutics is the diagnostic development and commercialization service provider. We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network. Our ultimate goal is to drive better testing to enable better treatment decisions for patients.

keywords:N/A

105

Number of Employees

$16.4M

Revenue (est)

1

Current Jobs

38%

Employee Growth %

$5.3M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
TCP Reliable
$7.8M420%
TCP Reliable
$7.8M420%
Shionogi
$87M4808%
Trio, An FCB He...
$7.8M40-2%
Vertice Pharma
$7M39-7%
Ortho Dermatolo...
$43.2M24212%
PRI Healthcare ...
$11.5M56-5%
TAIHO ONCOLOGY ...
$35.8M1949%
LEO Pharma Inc....
$42.4M2323%
Specialty Rx
$19.9M12317%

Diaceutics News

09/03/2019 - Diaceutics reports 34% jump in half year revenues in maiden results

Irish data analytics company Diaceutics reported a 34 per cent jump in half-year revenues in its maiden set of results as a publicly listed ...

09/08/2019 - Diaceutics Maiden Loss Deepens On Listing Costs; Revenue ...

(Alliance News) - Pharmaceuticals-focused data analytics firm Diaceutics PLC said Monday its maiden interim loss deepened amid listing costs ...

09/03/2019 - Diaceutics Plc ($DXRX): Caution Is Advised (2019-09-09)

On its latest session, Diaceutics Plc ($DXRX) opened at 94.5, reaching a high of 96.34 and a low of 92.0 before closing at a price of 92.5.

Diaceutics Funding

DateAmountRoundLead InvestorsReference
2018-04-06$5.0MUndisclosedWhiteRock Capital PartnersArticle

Diaceutics Executive Hires

DateNameTitleReference
2018-11-29Damian ThorntonCOOArticle

Diaceutics Hiring Plans

DateNumber of EmployeesLocationReference
2017-12-2950BelfastArticle
2018-10-2320Article